Cabinet Prive Dr. Sava

The neurology department at Cabinet Prive Dr. Sava is conducting research focused on the rapid relief of migraine attacks using a single oral dose of a CGRP receptor antagonist.

• Evaluation of single‑dose efficacy for acute migraine
• Comparison with placebo to confirm therapeutic benefit
• Assessment of safety and tolerability in adult patients

This work contributes to better acute care options for individuals suffering from frequent migraine episodes.

Studies at the site explore long‑term reduction of monthly migraine days in children with chronic migraine through monthly injections of a monoclonal antibody targeting the CGRP pathway.

• Monitoring change in migraine frequency over a 12‑week period
• Determining safety profile for pediatric use
• Evaluating sustained benefit beyond the double‑blind phase

Findings aim to expand preventive treatment choices for young patients living with disabling migraine patterns.